Patents by Inventor William Liang

William Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11992528
    Abstract: The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: May 28, 2024
    Assignee: CYTOMX THERAPEUTICS, INC.
    Inventors: Henry Bernard Lowman, Luc Roland Desnoyers, Tony W. Liang, Andrei William Konradi, Shweta Singh
  • Publication number: 20240160624
    Abstract: A distributed database system for handling transactions from multiple client systems. A database node receives a request to execute a transaction from a first client, involving a record modification. This record has an associated check-and-set (CAS) value that changes with modifications. The record is sent to the first client, which identifies the CAS value. Similarly, a second client sends a request for another transaction, receives the record, and identifies the CAS value. One of these clients attempts to stage a mutation based on their transaction. This includes sending the previously received CAS value. The system checks for a CAS value mismatch, indicating a conflicting mutation from another transaction. If a mismatch is detected, the transaction attempt is aborted to prevent conflicts. Otherwise, the mutation is staged, and the CAS value is updated.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Inventors: Graham Timothy Pople, Brett Phillip James Lawson, Matthew William Ingenthron, David John Finlay, Shivani Gupta, John Sae Liang, Stephen Ching-Sing Yen
  • Patent number: 11926669
    Abstract: The present disclosure relates to an anti-FcRn antibody or an antigen binding fragment thereof with improved stability and uses thereof. The anti-FcRn antibody or antigen binding fragment thereof binds to FcRn non-competitively with IgG and the like compared to the parent antibody, HL161AN, thereby having improved stability, such as reducing the production rate of aggregates while maintaining the biological activity of significantly reducing the amount of pathogenic autoantibodies in the blood. Therefore, it may be utilized more efficiently for the treatment of an autoimmune disease.
    Type: Grant
    Filed: June 23, 2023
    Date of Patent: March 12, 2024
    Assignees: HANALL BIOPHARMA CO., LTD., IMMUNOVANT SCIENCES GMBH
    Inventors: William Louis Macias, Su Liang, Hyeakyung Ahn, Haeyoung Yong, Mijin Jung, Minho Yoon, Eunsun Kim, Seungkook Park, Hyeeun Shim
  • Publication number: 20070003044
    Abstract: A method and system for providing a user who places a telephone call on hold with a partial hold option. When a user places a first call on partial hold and picks up a second call, the user can still hear conversation and activity that occurs on the first call. For example a user participating in a conference call may receive a second call. The user can place the conference call on partial hold and pick up a second call (i.e. engage in a conversation on a second telephone call). However, the incoming channel to the conference call will remain active and the user will be able to hear, in the background, what is taking place in the conference call.
    Type: Application
    Filed: June 23, 2005
    Publication date: January 4, 2007
    Applicant: Cisco Technology, Inc.
    Inventors: William Liang, Scott Henning